Tamra Lewis, MD
Urology · Lake Barrington, ILNPI 1639281926
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (58.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by Coloplast at 56.5% of the total. Among urology clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 283 payments — averaging $125.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$20K
- Axonics, Inc.$5K
- Medtronic$3K
- Healthtronics Stone Solutions, LLC$2K
- Ferring Pharmaceuticals Inc.$914
- Astellas Pharma US Inc$728
- plus $4K from 29 others
Across 39 payments — averaging $1446.79 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bluewind Medical$48K
- Boston Scientific$6K
- Axonics, Inc.$2K
What the payments were for
- Consulting fees$20,60558%
- Speaking & faculty fees$8472%
- Travel & lodging$3,81411%
- Food & beverage$7,86822%
- Education$2,3747%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 47 | $20,076 |
| Axonics, Inc. | 46 | $5,108 |
| Medtronic(2 entities) | 17 | $2,513 |
| Healthtronics Stone Solutions, LLC | 3 | $1,765 |
| Ferring Pharmaceuticals Inc. | 9 | $914 |
| Astellas Pharma US Inc | 27 | $728 |
| Sumitomo Pharma America, Inc. | 25 | $599 |
| Urogen Pharma, Inc. | 6 | $594 |
| Dendreon Pharmaceuticals LLC | 10 | $587 |
| Johnson & Johnson | 17 | $492 |
| AbbVie(2 entities) | 18 | $384 |
| Amgen | 6 | $344 |
| Boston Scientific | 7 | $327 |
| Myovant Sciences Inc. | 7 | $203 |
| Therapeuticsmd, Inc. | 7 | $134 |
| Novo Nordisk | 2 | $122 |
| Bayer | 4 | $96 |
| Bluewind Medical | 3 | $79 |
| 180 Medical, Inc. | 3 | $60 |
| Olympus America Inc. | 1 | $49 |
| Travere Therapeutics, Inc. | 2 | $41 |
| Verity Pharmaceuticals Inc. | 2 | $34 |
| Antares Pharma, Inc. | 2 | $28 |
| Immunitybio, Inc. | 1 | $26 |
| AstraZeneca | 1 | $24 |
| Cardinal Health 108 LLC | 1 | $23 |
| Teleflex LLC | 1 | $22 |
| Endo USA, Inc. | 1 | $21 |
| Laborie Medical Technologies Corp. | 1 | $20 |
| Avation Medical, Inc. | 1 | $18 |
| Avadel Specialty Pharmaceuticals, LLC | 1 | $18 |
| Endo Pharmaceuticals Inc. | 1 | $17 |
| Convatec Inc. | 1 | $17 |
| Pfizer | 1 | $16 |
| Neotract Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPEEDICATH$15,149
- Dornier MedTech$7,060
- Axonics$2,960
- Luja Coude$2,040
- CVAC Aspiration System$1,765
- Axonics r-SNM System$876
- Bulkamid$856
- ALTIS$818
- NOCDURNA$722
- JELMYTO$542
- INTERSTIM$482
- PROVENGE$330
- Erleada$233
- ALTAVIVA$217
- Solyx SIS System$149
- ORGOVYX$125
- Prolia$124
- AIMOVIG$123
- ZUSDURI$109
How this compares
$35,508 in reported general payments places this provider in the 90th percentile of 550 urology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 226 | $181,978 |
| GemtesaVibegron | 180 | $147,440 |
| Estradiol | 408 | $23,208 |
| Mirabegron ErMirabegron | 14 | $10,201 |
| ImvexxyEstradiol | 25 | $8,460 |
| Tolterodine Tartrate ErTolterodine Tartrate | 51 | $2,888 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 18 | $2,346 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 108 | $1,203 |
| Potassium Citrate ErPotassium Citrate | 11 | $1,189 |
| Trospium Chloride ErTrospium Chloride | 12 | $1,021 |
| Solifenacin Succinate | 50 | $956 |
| Tamsulosin Hcl | 50 | $437 |
| Amitriptyline Hcl | 14 | $329 |
| Gentamicin Sulfate | 11 | $177 |
| Cefadroxil | 22 | $128 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $728 | $181,978226 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $599 | $147,440180 claims |
| Therapeuticsmd, Inc.Imvexxy | $134 | $8,46025 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 550 urology providers in Illinois.
Other urology in Lake Barrington
- Mark BrandtPark Ridge$1.3M
- Aaron BergerChicago Ridge$583K
- Gary SteinbergChicago$529K
- Simone CrivellaroChicago$526K
- Brian HelfandChicago$517K
- Ashley RossChicago$404K
- Kevin McVarySpringfield$372K
- Richard HarrisMelrose Park$363K
- Amy KrambeckChicago$356K
- Kevin ZornChicago$274K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.